click below
click below
Normal Size Small Size show me how
Pain/Heme/Onc 1
with essential knowledge
| Generic | Brand | Category | Indication | Side Effects | US Box Warning | Other Notes | US Box Warning (2) |
|---|---|---|---|---|---|---|---|
| fentanyl (transdermal, IV) (CS-II) | Transdermal: Duragesic IV: Sublimaze | Opioid analgesic | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | Opioids risk addiction, misuse, fatal overdose, respiratory depression, accidental-ingestion death, neonatal or abrupt-discontinuation withdrawal, and when combined with benzodiazepines, alcohol, or other CNS depressants, sedation, coma, and death. | potential for medication errors when converting between dosage forms; use with CYP34A inhibitors (or stopping CYP3A4 inducers) can increase fentanyl concentrations; avoid exposing transdermal patch to external heat | |
| hydromorphone (PO, IV) (CS-II) | Dilaudid | Opioid analgesic | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | Opioids risk addiction, misuse, fatal overdose, respiratory depression, accidental-ingestion death, neonatal or abrupt-discontinuation withdrawal, and when combined with benzodiazepines, alcohol, or other CNS depressants, sedation, coma, and death. | risk of medication errors with high-potency hydromorphone, use in opioid-tolerant patients only | |
| morphine (extended-release) (PO) (CS-II) | MS Contin, Kadian | Opioid analgesic | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | Opioids risk addiction, misuse, fatal overdose, respiratory depression, accidental-ingestion death, neonatal or abrupt-discontinuation withdrawal, and when combined with benzodiazepines, alcohol, or other CNS depressants, sedation, coma, and death. | coingestion with alcohol may result in potentially fatal overdose of morphine | |
| morphine (immediate-release) (PO, IV, IM, PR) (CS-II) | IV: Duramorph, Infumorph | Opioid analgesic | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | Opioids risk addiction, misuse, fatal overdose, respiratory depression, accidental-ingestion death, neonatal or abrupt-discontinuation withdrawal, and when combined with benzodiazepines, alcohol, or other CNS depressants, sedation, coma, and death. | ||
| oxycodone (PO) | OxyContin, Roxicodone | Opioid analgesic | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | Opioids risk addiction, misuse, fatal overdose, respiratory depression, accidental-ingestion death, neonatal or abrupt-discontinuation withdrawal, and when combined with benzodiazepines, alcohol, or other CNS depressants, sedation, coma, and death. | use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase oxycodone concentrations | |
| methadone (PO, IV) (CS-II) | Dolophine | Opioid analgesic | Opioid use disorder, severe chronic pain | dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related), QTc prolongation | Opioids risk addiction, misuse, fatal overdose, respiratory depression, accidental-ingestion death, neonatal or abrupt-discontinuation withdrawal, and when combined with benzodiazepines, alcohol, or other CNS depressants, sedation, coma, and death. | QTc interval prologation and serious arrhythmia (Torsades de Pointes) have occurred during treatment; concomitant use with CYP3A4, 2B6, 2C19, or 2D6 (or stopping the same inducers) can increase methadone concentrations | |
| acetaminophen (PO, PR, IV) (OTC) | PO/PR: Tylenol IV: Ofirmev | Analgesic (non-opioid), antipyretic | Pain, fever | nausea, vomiting, increase hepatic transaminases | total daily dose from all sources should not exceed maximum daily limit; hepatotoxicity | ||
| tramadol (PO) (CS-IV) | Ultram, Ultram ER | Central analgesic; partial opioid agonist | Pain | dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related) | Risks: Addiction, abuse, and misuse may cause overdose and death. Serious or fatal respiratory depression and fatal accidental ingestion may occur. Prolonged use during pregnancy may cause neonatal opioid withdrawal syndrome. | lowers seizure threshold | Opioids & benzos/alcohol/CNS depressants = sedation, respiratory depression, coma/death; check CYP3A4/2D6 changes; tramadol = fatal respiratory depression in ultra-rapid-metabolizer children after tonsil/adenoidectomy. |